Clinic of the Month California Medical Group Netted $120K this month Zero ad spend See how
NAD+ vs. Peptide Therapy: Which Service Should Anchor Your Longevity Clinic Launch?

NAD+ vs. Peptide Therapy: Which Service Should Anchor Your Longevity Clinic Launch?

NAD+ vs. Peptide Therapy: Which Service Should Anchor Your Longevity Clinic Launch?Nova S.
Published on: 07/08/2026

NAD+ IV therapy versus peptide therapy as the anchor service for a new longevity clinic — operational complexity, patient demand, margins, and the decision framework for sequencing your launch.

Regenerative Health Services & Market Demand
Built by operators. Proven across 350+ clinic launches.